Trillium Asset Management’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q3
Sell
-3,140
Closed -$229K 221
2015
Q2
$229K Sell
3,140
-250
-7% -$18.1K 0.01% 200
2015
Q1
$222K Sell
3,390
-140
-4% -$9.31K 0.01% 202
2014
Q4
$230K Sell
3,530
-350
-9% -$22.5K 0.02% 197
2014
Q3
$233K Sell
3,880
-426
-10% -$27.8K 0.02% 181
2014
Q2
$298K Sell
4,306
-33,921
-89% -$2.2M 0.03% 171
2014
Q1
$2.5M Sell
38,227
-1,314
-3% -$85.5K 0.24% 120
2013
Q4
$2.45M Sell
39,541
-159
-0.4% -$9.21K 0.24% 116
2013
Q3
$2.13M Buy
39,700
+1,055
+3% +$54.3K 0.24% 110
2013
Q2
$1.76M Buy
+38,645
New +$1.67M 0.22% 104

Other funds holding STJ

Trillium Asset Management's STJ Position: Q3 2015 in Review

Trillium Asset Management sold out of St Jude Medical (STJ) in Q3 2015, closing a stake of 3,140 shares — an estimated $229K sold.

Trillium Asset Management first reported a position in STJ in Q2 2013 and held it in 9 quarters. The position peaked at $2.5M in Q1 2014. 618 funds tracked by Wall St. Rank hold STJ as of Q3 2015.

  • Trillium Asset Management reported no remaining St Jude Medical position as of Q3 2015 after selling out during the quarter.
  • Trillium Asset Management sold 3,140 St Jude Medical shares in Q3 2015, an estimated $229K.
  • Trillium Asset Management first reported a position in St Jude Medical in Q2 2013 and held it in 9 quarters.
  • Trillium Asset Management's St Jude Medical position peaked at $2.5M in Q1 2014.
  • 618 funds tracked by Wall St. Rank held St Jude Medical as of Q3 2015.

Based on Trillium Asset Management's 13F filing for Q3 2015, filed 2 Nov 2015.